Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.

[1]  A. Dibernardo,et al.  Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types , 2021, Journal of Clinical Virology.

[2]  Luisa Ganfini,et al.  Effect of Repeated Freeze–Thaw Cycles on Influenza Virus Antibodies , 2021, Vaccines.

[3]  Gheyath K Nasrallah,et al.  Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies , 2020, International Journal of Infectious Diseases.

[4]  Dongmu Zhang,et al.  Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study , 2019, BMC Public Health.

[5]  C. Hoebe,et al.  Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial. , 2019, The Lancet. Infectious diseases.

[6]  S. Kurosky,et al.  Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States. , 2018, Vaccine.

[7]  P. Easterbrook,et al.  Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers , 2017, BMC Infectious Diseases.

[8]  C. Hoebe,et al.  Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  F. Cutts,et al.  Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.

[10]  C. Lau,et al.  A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. , 2015, Vaccine.

[11]  Li Li,et al.  Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China , 2015, Human vaccines & immunotherapeutics.

[12]  Yi Feng,et al.  [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up]. , 2015, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[13]  C. Hoebe,et al.  High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  C. Hoebe,et al.  Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders. , 2012, Vaccine.

[15]  U. Heininger,et al.  Successful hepatitis B immunization in non- and low responding health care workers , 2010, Human vaccines.

[16]  J. Nelson,et al.  Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. , 2009, American journal of public health.

[17]  A. Frydén,et al.  Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. , 2008, The Journal of infectious diseases.

[18]  D. Neumann-Haefelin,et al.  Comparison of Nine Commercially Available Assays for Quantification of Antibody Response to Hepatitis B Virus Surface Antigen , 2008, Journal of Clinical Microbiology.

[19]  G. Drusano,et al.  Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. , 2003, Vaccine.

[20]  P. Wollan,et al.  Effect of Multiple Freeze-Thaw Cycles on Detection of Measles, Mumps, and Rubella Virus Antibodies , 2003, Clinical Diagnostic Laboratory Immunology.

[21]  K. Leder,et al.  The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  G. Moens,et al.  The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. , 2002, Vaccine.

[23]  H. Whittle,et al.  What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.

[24]  B. McMahon,et al.  Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. , 1997, The Journal of infectious diseases.

[25]  S. Hadler,et al.  Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. , 1986, The New England journal of medicine.